Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 13, 2021 |
Feb. 09, 2021 |
Feb. 06, 2021 |
Jan. 27, 2021 |
Dec. 08, 2020 |
Nov. 03, 2020 |
Feb. 28, 2021 |
Sep. 17, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Mar. 16, 2021 |
Nov. 02, 2020 |
|
| Equity (Details) [Line Items] | ||||||||||||
| Aggregate shares of common stock | 1,560,000 | |||||||||||
| Offering cost (in Dollars) | $ 1,430,000 | |||||||||||
| Warrants exercise price (in Dollars per share) | $ 1.99 | |||||||||||
| Warrants expire term | 5 years 6 months | |||||||||||
| Common stock price per share (in Dollars per share) | $ 5.97 | |||||||||||
| Common stock issued | 60,000 | |||||||||||
| Consecutive trading days | 20 days | |||||||||||
| Purchase price | 3.1 | |||||||||||
| Aggregate net proceeds (in Dollars) | $ 26,100,000 | $ 12,400,000 | $ 4,836,000 | $ 1,111,069 | ||||||||
| Exercise price (in Dollars per share) | $ 3.1 | |||||||||||
| Term expire | 3 years 6 months | |||||||||||
| Aggregate share of common stock | 3,655,000 | 1,998,500 | 1,086,956 | |||||||||
| Purchase price for each share of common stock and warrants (in Dollars per share) | $ 3.68 | |||||||||||
| Exercise price (in Dollars per share) | $ 5 | |||||||||||
| Warrant exercise term, description | The Warrants will be exercisable at any time during the period beginning on or after July 27, 2021 and ending on or prior on January 27, 2026 but not thereafter; provided, however, that the total number of the Company’s issued and outstanding shares of Common Stock, multiplied by the NASDAQ official closing bid price of the Common Stock shall equal or exceed $0.3 billion for a three consecutive month period prior to an exercise. | |||||||||||
| Purchase price per shares (in Dollars per share) | $ 7.8 | $ 6.805 | ||||||||||
| Common stock exercise price (in Dollars per share) | $ 7.8 | $ 6.805 | ||||||||||
| Stock based compensation description | (the “Company”) and the Compensation Committee of the Board (the “Committee”) approved a one-time award of a total of 1,020,000 of the common stock from the shares reserved under the Company’s 2014 Stock Incentive Plan (the “Plan”) to (i) Chief Executive Officer, Lei Cao, is entitled to a one-time stock award grant of 600,000 shares, (ii) acting Chief Financial Officer, Tuo Pan, is entitled to a one-time stock award grant of 200,000 shares, (iii) Board member, Zhikang Huang, is entitled to a one-time stock award grant of 160,000 shares, (iv) Board member, Jing Wang, is entitled to a one-time stock award grant of 20,000 shares, (v) Board member, Xiaohuan Huang, is entitled to a one-time stock award grant of 20,000 shares, and (vi) Board member, Tieliang Liu, is entitled to a one-time stock award grant of 20,000 shares. | |||||||||||
| Stock-based compensation expense (in Dollars) | $ 2,927,400 | |||||||||||
| Securities Purchase Agreements [Member] | ||||||||||||
| Equity (Details) [Line Items] | ||||||||||||
| Aggregate shares of common stock | 1,170,000 | 720,000 | ||||||||||
| Warrant [Member] | ||||||||||||
| Equity (Details) [Line Items] | ||||||||||||
| Aggregate shares of common stock | 1,998,500 | |||||||||||
| Purchase of warrants | 720,000 | |||||||||||
| Purchase price per share (in Dollars per share) | $ 1.46 | |||||||||||
| Net proceeds (in Dollars) | $ 1,050,000.00 | |||||||||||
| Warrants price per share (in Dollars per share) | $ 1.825 | |||||||||||
| Description of warrant rights | The warrants will expire on March 16, 2026. The warrants are subject to anti-dilution provisions to reflect stock dividends and splits or other similar transactions. The warrants contain a mandatory exercise right for the Company to force exercise the warrants if the Company’s common stock trades at or above $4.38 for 20 consecutive trading days, provided, among other things, that the shares issuable upon exercise of the are registered or may be sold pursuant to Rule 144 and the daily trading volume exceeds 60,000 shares of common stock per trading day on each trading day in a period of 20 consecutive trading days prior to the applicable date. | |||||||||||
| Aggregate share of common stock | 3,655,000 | 5,434,780 | ||||||||||
| Net proceeds of offering (in Dollars) | $ 4,000,000 | |||||||||||
| Common Stock [Member] | ||||||||||||
| Equity (Details) [Line Items] | ||||||||||||
| Preferred stock conversion | 860,000 | |||||||||||
| Series A Convertible Preferred Stock [Member] | ||||||||||||
| Equity (Details) [Line Items] | ||||||||||||
| Warrants price per share (in Dollars per share) | $ 1.66 | |||||||||||
| Aggregate issued shares | 860,000 | |||||||||||
| Warrants to purchase of common stock | 1,032,000 | |||||||||||
| Preferred stock conversion | 860,000 | |||||||||||